Mesa Laboratories Statistics
Total Valuation
MLAB has a market cap or net worth of $636.33 million. The enterprise value is $815.65 million.
Important Dates
The next estimated earnings date is Friday, May 30, 2025, before market open.
| Earnings Date | May 30, 2025 |
| Ex-Dividend Date | May 30, 2025 |
Share Statistics
MLAB has 5.43 million shares outstanding. The number of shares has increased by 0.31% in one year.
| Current Share Class | 5.43M |
| Shares Outstanding | 5.43M |
| Shares Change (YoY) | +0.31% |
| Shares Change (QoQ) | -0.77% |
| Owned by Insiders (%) | 2.56% |
| Owned by Institutions (%) | 94.77% |
| Float | 5.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 15.91 |
| PS Ratio | 2.66 |
| Forward PS | 2.51 |
| PB Ratio | 4.10 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 14.80 |
| P/OCF Ratio | 13.53 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 18.58, with an EV/FCF ratio of 18.97.
| EV / Earnings | n/a |
| EV / Sales | 3.43 |
| EV / EBITDA | 18.58 |
| EV / EBIT | 39.64 |
| EV / FCF | 18.97 |
Financial Position
The company has a current ratio of 0.71, with a Debt / Equity ratio of 1.36.
| Current Ratio | 0.71 |
| Quick Ratio | 0.46 |
| Debt / Equity | 1.36 |
| Debt / EBITDA | 4.40 |
| Debt / FCF | 4.92 |
| Interest Coverage | 1.83 |
Financial Efficiency
Return on equity (ROE) is -89.38% and return on invested capital (ROIC) is 2.54%.
| Return on Equity (ROE) | -89.38% |
| Return on Assets (ROA) | 2.18% |
| Return on Invested Capital (ROIC) | 2.54% |
| Return on Capital Employed (ROCE) | 7.32% |
| Revenue Per Employee | $323,026 |
| Profits Per Employee | -$338,917 |
| Employee Count | 736 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 2.69 |
Taxes
| Income Tax | -20.39M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +11.83% in the last 52 weeks. The beta is 0.92, so MLAB's price volatility has been similar to the market average.
| Beta (5Y) | 0.92 |
| 52-Week Price Change | +11.83% |
| 50-Day Moving Average | 125.25 |
| 200-Day Moving Average | 125.37 |
| Relative Strength Index (RSI) | 49.63 |
| Average Volume (20 Days) | 53,197 |
Short Selling Information
The latest short interest is 224,295, so 4.13% of the outstanding shares have been sold short.
| Short Interest | 224,295 |
| Short Previous Month | 186,715 |
| Short % of Shares Out | 4.13% |
| Short % of Float | 4.24% |
| Short Ratio (days to cover) | 4.00 |
Income Statement
In the last 12 months, MLAB had revenue of $237.75 million and -$249.44 million in losses. Loss per share was -$46.13.
| Revenue | 237.75M |
| Gross Profit | 151.48M |
| Operating Income | 20.58M |
| Pretax Income | -270.81M |
| Net Income | -249.44M |
| EBITDA | 43.90M |
| EBIT | 20.58M |
| Loss Per Share | -$46.13 |
Full Income StatementBalance Sheet
The company has $32.29 million in cash and $211.61 million in debt, giving a net cash position of -$179.32 million or -$33.00 per share.
| Cash & Cash Equivalents | 32.29M |
| Total Debt | 211.61M |
| Net Cash | -179.32M |
| Net Cash Per Share | -$33.00 |
| Equity (Book Value) | 155.21M |
| Book Value Per Share | 28.57 |
| Working Capital | -45.03M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $47.03 million and capital expenditures -$4.03 million, giving a free cash flow of $43.00 million.
| Operating Cash Flow | 47.03M |
| Capital Expenditures | -4.03M |
| Free Cash Flow | 43.00M |
| FCF Per Share | $7.91 |
Full Cash Flow StatementMargins
Gross margin is 63.71%, with operating and profit margins of 8.66% and -104.92%.
| Gross Margin | 63.71% |
| Operating Margin | 8.66% |
| Pretax Margin | -113.50% |
| Profit Margin | -104.92% |
| EBITDA Margin | 18.47% |
| EBIT Margin | 8.65% |
| FCF Margin | 18.09% |
Dividends & Yields
This stock pays an annual dividend of $0.64, which amounts to a dividend yield of 0.55%.
| Dividend Per Share | $0.64 |
| Dividend Yield | 0.55% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.31% |
| Shareholder Yield | 0.24% |
| Earnings Yield | -39.20% |
| FCF Yield | 6.76% |
Dividend DetailsAnalyst Forecast
The average price target for MLAB is $140.00, which is 19.55% higher than the current price. The consensus rating is "Hold".
| Price Target | $140.00 |
| Price Target Difference | 19.55% |
| Analyst Consensus | Hold |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MLAB has an Altman Z-Score of 1.28 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.28 |
| Piotroski F-Score | 6 |